The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 24, 2024
Filed:
Sep. 03, 2019
Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Jiangsu, CN;
Lianyungang Runzhong Pharmaceutical Co., Ltd., Lianyungang, CN;
Centaurus Biopharma Co., Ltd., Beijing, CN;
Yuanyuan Sun, Lianyungang, CN;
Shan Zhou, Lianyungang, CN;
Lei Liu, Lianyungang, CN;
Ping Dong, Lianyungang, CN;
Jing Gao, Lianyungang, CN;
Laicun Li, Lianyungang, CN;
Zhilin Chen, Lianyungang, CN;
Yi Xu, Lianyungang, CN;
Shang Wang, Lianyungang, CN;
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD., Lianyungang, CN;
LIANYUNGANG RUNZHONG PHARMACEUTICAL CO., LTD., Lianyungang, CN;
CENTAURUS BIOPHARMA CO., LTD., Beijing, CN;
Abstract
A solid pharmaceutical composition containing a 1,3,5-triazine derivative or a pharmaceutically acceptable salt thereof and a preparation method therefor. In particular, involved are a solid pharmaceutical composition containing 4-(tert-butoxyamino)-6-(6-(trifluoromethyl)pyridin-2-yl)-N-(2-(trifluoromethyl)pyridin-4-yl)-1,3,5-triazine-2-amine or a pharmaceutically acceptable salt thereof and a preparation method therefor. The solid pharmaceutical composition has a good stability, a fast dissolution rate and a high bioavailability, and is suitable for clinical production and use.